Ran-irbesartan Product Recall (2021-05-27)

RAN-Irbesartan Recall Summary RAN-Irbesartan, a blood pressure medication, was recalled across Canada due to product safety concerns. The recall is classified as Class I, indicating a serious safety issue. This recall affects all Canadian consumers who have been prescribed or are using this medication.

Reason
Product safety
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2021-05-27
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/d5fa38a6-bd59-4dcc-bc4a-6ad9747c7423